Citation Information :
Radončić E. The Ethical, Legal, and Social Issues Impacted by Assisted Reproductive Technologies in Croatia. Donald School J Ultrasound Obstet Gynecol 2023; 17 (1):74-78.
Background: While assisted reproductive technology (ART), including in vitro fertilization (IVF), has given hope to millions of couples suffering from infertility, it has also introduced countless ethical, legal, and social challenges. The objective of this paper is to identify the influence of legislation and discuss various ethical, legal, and social aspects of ART in Croatia through various periods after its introduction in infertility treatment.
Scope of review: This paper gives a short review and depicts the ethical, legal, and social challenges they introduce influenced by past and contemporary legislation in Croatia.
Conclusion: In the future, advancing technology is likely to exacerbate the existing and open even more new ethical, legal, and social challenges. The ethical issues surrounding ART are complex and multifaceted, and they can be difficult to navigate. ART is directly challenging society to reevaluate the way in which human life, social justice, and equality are viewed. This is especially true for legislation whom which is expected to modify existing laws to accommodate the unique contemporary challenges created by ART.
Ombelet W, Cooke I, Dyer S, et al. Infertility and the provision of infertility medical services in developing countries. Hum Reprod Update 2008;14(6):605–621. DOI: 10.1093/humupd/dmn042
Ministry of Health of Republic of Croatia. 2019 annual ART report. https://zdravlje.gov.hr/UserDocs. Ministry of health of republic of Croatia. 2019 Annual ART report. https://zdravlje.gov.hr/UserDocsImages/2021Objave/Godi%C5%A1nje%20izvje%C5%A1%C4%87e%20o%20MPO%20aktivnostima%20za%202019.pdf (Croatian language).
Jones HW, Cooke I, Kempers R, et al. International federation of fertility societies surveillance. Fertil Steril 2011;95(2):491. DOI: 10.1016/j.fertnstert.2010.08.011
Schoolcraft W, Meseguer M. Paving the way for a gold standard of care for infertility treatment: improving outcomes through standardization of laboratory procedures. Reprod Biomed Online 2017;35(4):391–399. DOI: 10.1016/j.rbmo.2017.06.023
Vaughan DA, Leung A, Resetkova N, et al. How many oocytes are optimal to achieve multiple live births with one stimulation cycle? The one-and-done approach. Fertil Steril 2017;107(2):397–404. DOI: 10.1016/j.fertnstert.2016.10.037
Fragouli E, Alfarawati S, Spath K, et al. Morphological and cytogenetic assessment of cleavage and blastocyst stage embryos. Mol Hum Reprod 2014;20(2):117–126. DOI: 10.1093/molehr/gat073
Alviggi C, Conforti A, Carbone IF, et al. Influence of cryopreservation on perinatal outcome after blastocyst- vs cleavage-stage embryo transfer: systematic review and meta-analysis. Ultrasound Obstet Gynecol 2018;51(1):54–63. DOI: 10.1002/uog.18942
Marca A, Minasi MG, Sighinolfi G, et al. Female age, serum antimüllerian hormone level, and number of oocytes affect the rate and number of euploid blastocysts in in vitro fertilization/intracytoplasmic sperm injection cycles. Fertil Steril 2017;108(5):777–783. DOI: 10.1016/j.fertnstert.2017.08.029
Ballesta-Castillejos A, Gomez-Salgado J, Rodriguez-Almagro J, et al. Obstetric and perinatal complications associated with assisted reproductive treatment in Spain. J Assist Reprod Genet 2019;36(12):2435–2445. DOI: 1007/s10815-019-01631-6
Volmer L, Rösner S, Toth B, et al. Infertile partners coping strategies are interrelated – Implications for targeted psychological counseling. Geburtshilfe Frauenheilkd 2017;77(1):52–58. DOI: 10.1055/s-0042-119200
Kirkman-Brown J, Calhaz-Jorge C, Dancet EAF, et al. Good practice recommendations for information provision for those involved in reproductive donation. Hum Reprod Open 2022;2022(1):hoac001. DOI: 10.1093/hropen/hoac001
Zaami S, Gullo G, Varone MC, et al. From the maternal uterus to the “uterus device”? Ethical and scientific considerations on partial ectogenesis. Eur Rev Med Pharmacol Sci 2021;25(23):7354–7362. DOI: 10.26355/eurrev_202112_27429
Fiala C, Arthur JH. There is no defence for ‘conscientious objection’ in reproductive health care. Europ J Obs Gynecol Reprod Bio 2017;216:254–258. DOI: 10.1016/j.ejogrb.2017.07.023